Cargando…
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
The most important limitations of chemotherapeutic agents are severe side effects and the development of multi-drug resistance. Recently, the clinical successes achieved with immunotherapy have revolutionized the treatment of several advanced-stage malignancies, but most patients do not respond and...
Autores principales: | Boggio, Elena, Gigliotti, Casimiro Luca, Stoppa, Ian, Pantham, Deepika, Sacchetti, Sara, Rolla, Roberta, Grattarola, Margherita, Monge, Chiara, Pizzimenti, Stefania, Dianzani, Umberto, Dianzani, Chiara, Battaglia, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057931/ https://www.ncbi.nlm.nih.gov/pubmed/36986798 http://dx.doi.org/10.3390/pharmaceutics15030937 |
Ejemplares similares
-
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation
por: Puricelli, Chiara, et al.
Publicado: (2023) -
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo
por: Stoppa, Ian, et al.
Publicado: (2022) -
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
por: Monge, Chiara, et al.
Publicado: (2022) -
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering
por: Gigliotti, Casimiro Luca, et al.
Publicado: (2023) -
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review
por: Puricelli, Chiara, et al.
Publicado: (2022)